🌟 Differentiation and a localised strategy are crucial for UK/European life sciences innovators aiming to enter the US market. Our guide provides: 🔹 Steps for analysing your landscape 🔹 Developing compelling partner propositions 🔹 Effective pitch creation 🔹 Strategic collaboration models beyond traditional distribution Read on to learn how perseverance and expert support can unlock tremendous rewards in the US. https://lnkd.in/ez66-9E7 #LifeSciences #USMarketEntry #BusinessStrategy
Go To Market Global’s Post
More Relevant Posts
-
🌟 Breaking into the US life sciences market? Our guide covers everything from identifying channel partners to navigating regulations. #LifeSciences #USMarket #BusinessStrategy https://lnkd.in/eeBxQZaj
🚀 Breaking into the US life sciences market is a significant opportunity for UK and European scaleups but comes with its challenges. Our latest guide covers essential strategies for identifying and securing the right channel partners. Learn about: 🔹 The vast US distribution landscape 🔹 Crafting compelling partner value propositions 🔹 Navigating stringent regulations 🔹 Innovative collaboration models 🔹 The importance of persistence Check out the guide here: https://lnkd.in/ez66-9E7 #LifeSciences #USMarket #ChannelPartners Mark Stimpfig Tamara Medina Chris Howie Mindy Daeschner Ian Collins
Cracking the US Market: Life Sciences Scaleups' Guide to Finding the Right Channel Partners - GTM Global
https://gotomarket.global
To view or add a comment, sign in
-
🚀 Breaking into the US life sciences market is a significant opportunity for UK and European scaleups but comes with its challenges. Our latest guide covers essential strategies for identifying and securing the right channel partners. Learn about: 🔹 The vast US distribution landscape 🔹 Crafting compelling partner value propositions 🔹 Navigating stringent regulations 🔹 Innovative collaboration models 🔹 The importance of persistence Check out the guide here: https://lnkd.in/ez66-9E7 #LifeSciences #USMarket #ChannelPartners Mark Stimpfig Tamara Medina Chris Howie Mindy Daeschner Ian Collins
Cracking the US Market: Life Sciences Scaleups' Guide to Finding the Right Channel Partners - GTM Global
https://gotomarket.global
To view or add a comment, sign in
-
Embrace the journey towards excellence! The path to achieving market access excellence can be complex, but as many companies have discovered, a strategic integrated evidence generation plan is the key to unlocking success. Consider the story of a health tech company that faced hurdles while trying to bring their innovative solution to market. With a clear strategy and evidence-driven approach, they successfully navigated regulatory challenges, built stakeholder trust, and ultimately changed lives. The lesson here is straightforward: having a well-defined plan that integrates evidence generation can transform obstacles into opportunities. As you think about your own strategies, remember: insight is power, and preparation is everything. I’d love to hear your own stories of perseverance and success in achieving goals. What strategies have worked for you? https://lnkd.in/dibbv-AA CapSys Group
CapSys Group - Achieving Market Access Excellence with a Strategic Integrated Evidence Generation Plan
https://capsysgroup.com
To view or add a comment, sign in
-
Managing Partner, Sosna + Co. | Life Science Business Development | Matchmaker | Helping leaders expedite deals to drive growth | Podcast Host 🎙
I once was approached by a pharma start-up having a hard time finding a strategic partner. Basically, they needed $$$ and scientific support to get their drug (a phase I asset) to the next level. Normally this is a straightforward process. But the drug was in the cardiovascular space - a very competitive sector, making it harder to secure a partnership. That didn’t phase us. My team and I got straight to work on a partnership strategy. We leveraged our relationships and network, filtered companies based on fit, and began reaching out. In other words, we worked our signature process. Before long, we had closed a $5 million deal with a Fortune 500 partner. Sharing this because all companies at some point or another need support to get to the next level. No matter the company size, project, geography, or therapeutic area. 👉Read the case study: https://buff.ly/4gggQGn If this speaks to you, let’s book a 30-minute discovery call to see what we can do together: https://buff.ly/4183pRG #strategicpartnerships #partnerships #strategicpartner #businessdevelopment #businessdevelopmentexecutive
To view or add a comment, sign in
-
Just released: "The Ultimate Guide to the US Life Sciences Ecosystem & Supply Chain". Discover key players, market trends, and regulatory insights. Download your free copy now! #LifeSciences #SupplyChain #USMarket https://lnkd.in/eQY5MHcp
We just released "The Ultimate Guide to the US Life Sciences Ecosystem & Supply Chain" in association with Frazier & Deeter and QRx Partners. Here’s a sneak peek: 🌟 An overview of key players in the industry 🌟 Insights into technology partnerships and M&A activity 🌟 A comprehensive directory of essential organisations 🌟 Strategies for market access and regulatory compliance Ready to explore the US life sciences market? Get your free guide here: https://lnkd.in/efBEiK7S #LifeSciences #SupplyChain #USMarket Chris Howie Mindy Daeschner
The Essential US Market Entry Guide for Life Science Companies - GTM Global
https://gotomarket.global
To view or add a comment, sign in
-
🚀 Unlocking Success: Navigate Your Way Through Generic and Value-Added Medicines! 🌟 Get ready for an eye-opening session led by Ana Gavaldá, Founder & CEO of Annion, as she joins us once again with a new Case Study + Workshop ! 🔍 What's Inside: · Portfolio Mastery: Learn how to wield portfolio management like a pro and boost your organizational efficiency. · The generic industry landscape: Dive deep into the challenges and opportunities of the generics market. · Crafting a Winning Generic Portfolio: Discover strategies to build a robust portfolio that stands out. · Stepping Up with VAMs: Explore the latest in Value-Added Medicines (505(b)2) and seize new opportunities. · Hands-On Workshop: Roll up your sleeves and learn how to evaluate and select Value Added Medicines effectively. Ready to elevate your strategy? Secure your spot and join us for a dose of innovation and insights! 🚀 https://lnkd.in/gi2TdJpk #PPM #Barcelona #PortfolioOptimization
To view or add a comment, sign in
-
Expert in Business Strategy, Customer Centricity and Customer Experience. Lecturer and Speaker. Top Management Advisor
This is a really interesting read on the success requirements for the MARKET ACCESS function in pharma. I had the pleasure of being part of the team conducting interviews with leading experts and top industry executives and writing the ”RE-THINKING MARKET ACCESS“ series of articles. #pharmaceuticals #pharmaceuticalindustry #pharma #lifesciences #marketaccess #strategyconsulting #marketaccessexcellence
Achieving Market Access Excellence requires a strategic approach that encompasses both technical and organizational success requirements. To make it happen, at CapSys Group we have identified six crucial factors that must be in place. Technical success requirements include: 1. Gaining deep knowledge of stakeholders and the market access landscape. 2. Generating timely and relevant evidence to support market access. 3. Engaging effectively with stakeholders. 4. Demonstrating value propositions through effective communication. These technical requirements are underpinned by two organizational ones: 5. Investing in and improving the relevant organizational skills and capabilities. 6. Developing a clear and effective organizational setup. The study conducted interviews with industry experts and KOLs in Market Access from small to large pharmaceutical and life sciences organizations, providing insights on how to overcome challenges. CapSys provides the Market Access Excellence Canvas, a framework to assess the organization's maturity level on the path to Market Access Excellence. For additional insights and implications, visit our website to sign up and download the components of the CapSys Market Access Excellence Canvas pack. https://lnkd.in/dyyB6F85 #MarketAccessExcellence #OrganizationalSuccess #BusinessSuccess
To view or add a comment, sign in
-
🔬 Are you in the life sciences industry? Don’t miss out on our comprehensive guide to the US ecosystem and supply chain. Learn about key players, regulatory landscapes, and more. Get your free copy today and start navigating the US market with confidence. https://lnkd.in/efBEiK7S #LifeSciences #USMarket #FreeGuide Frazier & Deeter QRx Partners
The Essential US Market Entry Guide for Life Science Companies - GTM Global
https://gotomarket.global
To view or add a comment, sign in
-
Managing Partner, Sosna + Co. | Life Science Business Development | Matchmaker | Helping leaders expedite deals to drive growth | Podcast Host 🎙
Why are partnerships a game-changer for biotech and pharma companies? Here are insights from my 18 years as a life science “matchmaker” 1️⃣ Broaden your scope - partnerships allow you to access specialized and diverse therapeutic areas you might otherwise miss 2️⃣ Discover the hidden - unmet medical needs are no longer out of sight. Partnering helps you identify valuable assets you may have overlooked. 3️⃣ Overcome early-stage challenges - biotech companies gain the necessary resources to navigate early-stage development hurdles, making the journey less financially strenuous 4️⃣ Amplify R&D efforts - together, you and your partner can tackle large-scale R&D and clinical research projects that would be financially unfeasible for either party alone These are just a few benefits of partnering. Want to learn more, including the steps I use to form successful partnerships for my clients? Join my email list: https://lnkd.in/eE9N7dzK Need help securing your next strategic partner? Book a call: https://lnkd.in/e5yxzS7Y
To view or add a comment, sign in
-
🌟 Recognizing Landmark Deals in Life Sciences! 🌟 Nominate now for the Deal of the Year (<€500m) award at the European Lifestars Awards! This award recognizes the teams and organizations that have executed a truly transformational deal, significantly impacting both the company and the wider industry. Whether it's a licensing agreement, co-development, or a partnership, we want to celebrate your success! This prestigious award acknowledges deals that excel in: 🌟 Uniqueness or novelty of deal strategy, terms, and structure 💶 Level of value creation and size of the deal 🤝 Strength of partner, partnership, and deal teams 🔮 Potential game-changing implications within the next 12 months 📈 Post-deal performance To qualify, deals must: - Have a total deal size (not milestone payments) less than €500m - Involve a European Life Science company as the lead - Be open to private or public companies with pharma, commercial leaders, or big tech - Be a license, partnership, or alliance between companies (NOT M&A) - Have completed between 1 September 2023 and 1 August 2024 Nominate a deserving team today and help us honor their groundbreaking achievements and contributions to the European life sciences industry! 👉 Submit your nomination here: https://lnkd.in/ezjTkn6f ✨ Get inspired by last year’s winner: Watch the video of Ariceum Therapeutics and UCB’s success story, then nominate this year’s standout performer! #LifestarsAwards #DealOfTheYear #Innovation #LifeSciences #Partnerships
To view or add a comment, sign in
1,531 followers